Ovid Therapeutics Inc.
OVID
$2.70
-$0.05-1.82%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -15.01M | -16.99M | 9.66M | -12.16M | -4.68M |
| Total Depreciation and Amortization | 16.00K | 35.00K | 17.00K | 16.00K | 99.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.03M | 722.00K | -20.22M | 961.00K | 1.06M |
| Change in Net Operating Assets | -3.64M | 2.33M | 134.00K | -1.69M | -1.24M |
| Cash from Operations | -17.59M | -13.90M | -10.41M | -12.87M | -4.77M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -86.74M | 5.95M | -72.06M | 5.05M | 12.05M |
| Cash from Investing | -86.74M | 5.95M | -72.06M | 5.05M | 12.05M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 23.97M | 86.62M | 75.18M | 15.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -2.37M | 2.37M | -- | -- | -- |
| Cash from Financing | 21.60M | 88.98M | 75.18M | 15.00K | 0.00 |
| Foreign Exchange rate Adjustments | -4.00K | -122.00K | -167.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -82.74M | 80.91M | -7.46M | -7.80M | 7.28M |